Résultats de la recherche - 28 results
Annual report Belgian Cystic Fibrosis Registry 2020
Manuscript versions: DOI: http://x File: Version: Pre-print Full text access: Under Embargo Embargo end date: 31-12-2024 Full text language: English Category: E11 FOS Classification: 3.02 Clinical ...
Annual Report Belgian Cystic Fibrosis Registry 2021
Publication Type: Sci. report, recommendat°, guidance doc., directive, monograph Authors: Simeon Wanyama; Géraldine Daneau; Lieven Dupont; Kim Van Hoorenbeeck Source: Sciensano, Brussels, Belgium, ...
Clinical Evolution and Disease Burden in Belgian Cystic Fibrosis Patients: effect of Newborn Screening?
1 year of age were better in NBS patients (median =-0.13, IQR-0.99 – 0.50) compared to non- NBS patients (MI median =-0.56, IQR =-01.53 – 0.02, non- NBS median =-0.54, IQR =-1.02 – 0.12, p = 0.03377). ...
WS03.03 Clinical outcomes and long-term survival in cystic fibrosis (CF) lung transplant recipients in Belgium
Publication Type: Scientific poster, presentation or proceeding Authors: Thomas, M.; Dupont, L.; Knoop, C.; Wanyama, S.; Evrard, P.; Rondelet, B.; Kuylen, M. Vander; Van Muylem, A.; Van Raemdonck, ...
P142 Review of diagnostic labels for patients with unconfirmed cystic fibrosis diagnosis using registry data
Publication Type: Scientific poster, presentation or proceeding Authors: Wanyama, S. Situma; Daneau, G.; De Wachter, E.; Dupont, L. Source: Journal of Cystic Fibrosis, Volume 22, Vienna, Austria ...
P146 COVID-19 pandemic in the Belgian cystic fibrosis patients compared with the international cystic fibrosis patients and the general Belgian population
Publication Type: Scientific poster, presentation or proceeding Authors: Daneau, G.; Wanyama, S. Situma; Van Hoorenbeeck, K. Source: Journal of Cystic Fibrosis, Volume 22, Vienna, Austria (2023) ...
Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe.
lung-transplanted (28.6; 95% CI: 22.7-35.5) non-lung-transplanted pwCF (16.6; 95% CI: 15.4-17.8) (p≤0.001). SARS-CoV-2 infection caused symptomatic illness in 75.7%. Factors associated with symptomatic SARS-CoV-2 ...
COVID-19 vaccine prioritisation for people with cystic fibrosis.
Vicente R F da Silva; Anne L Stephenson; Stephanie Y Cheng; Joel Melo; Harriet Corvol; Pierre-Régis Burgel; Nährlich, Lutz; Edward McKone; Colombo, Carla; Marco Salvatore; Rita Padoan; Olzhas Abdrakhmanov; ...
Annual Report Belgian Cystic Fibrosis Registry 2018
60 mmol/L ; 2 had no sweat chloride value yet by December 2018. Among the patients followed-up in 2018, 51.9% were male and 64.3% adults, and the median age was 23.6 years. At inception of the ...
The global impact of SARS-CoV-2 in 181 people with cystic fibrosis
Nataliya; Bruce C Marshall; Edward McKone; Middleton, Peter G; Pedro Mondejar-Lopez; Dolores M Pastor-Vivero; Rita Padoan; Samar Rizvi; Rasa Ruseckaite; Marco Salvatore; Anne Stephenson; Filho, Luiz Vicente ...